Rampart Bioscience

United States
San Diego, California, United States, 95315

Company profile

Rampart Bioscience company profile

Rampart Bioscience develops gene medicines to provide long-lasting treatments for a wide range of diseases. It also offers proprietary development and delivery platforms, which together, create optimized therapeutics in a revocable, non-viral format. It also assists patients with genetically driven diseases by integrating capabilities from a variety of key scientific disciplines including gene delivery, protein sciences, and clinical translation.

Business identity

Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Founded
2019-01-01, Year

Headquarters

Postal code
95315
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
1
Total equity funding
$85M
Last funding
Series A / $85M / 2023-10-24
Last equity funding
Series A / $85M
Investors
4
Lead investors
1
Founders
1
Articles
12

Founders and investors

Founders

Louis Breton

Lead investors

Forbion Capital Partners

Investors

Forbion Capital PartnersHealthCapOrbiMedRA Capital Management